Boelaert 1989.

Methods	Double‐blind, randomised controlled trial
Participants	Hemodialysis patients. All carriers. Mupirocin: 17. Placebo: 18. No significant difference between both groups.
Interventions	Mupirocin or placebo. Thrice daily for 2 weeks and subsequent 3 times weekly for a total of 9 months.
Outcomes	S. aureus infection rate Mortality Adverse events
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment?	Unclear risk	Unclear
Blinding? participants	Low risk
Blinding? outcome assessor	Low risk
Intention to treat	Low risk	not reported but confirmed
Loss to follow up	Low risk	Mupirocin:41 Placebo:17